Multiple sclerosis Nervous System Diseases
Conditions
Interventions
This is a multi-phase hybrid effectiveness-implementation study to test the effectiveness of the READY for MS intervention when NHS healthcare professionals are trained to support it for people with m
Sponsors
Leeds Teaching Hospitals NHS Trust
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Participants capable of giving informed consent 2. Aged 18 years or above 3. Currently in paid employment with an intention to remain in employment for at least 6 months Phase 2: A registered healthcare professional or allied health professional who works in direct contact with patients diagnosed with Multiple Sclerosis Phase 3: An individual with a clinical diagnosis of Multiple Sclerosis and reporting a WI score >= 11/22 (on MS-WIS)
Exclusion criteria
Exclusion criteria: 1. Individuals lacking the capacity to give informed consent 2. Individuals intending to leave paid employment within the next 6 months 3. Individuals who will not have access to a device used to access the internet (e.g. laptop or smartphone) for the duration of study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PwMS phase: 1. Work instability is measured using the Multiple Sclerosis work instability scale at baseline, week 8, and month 6 2. Resilience is measured using the Connor-Davidson Resilience Scale at baseline, week 8, and month 6 3. Psychological flexibility is measured using the Multi-dimensional psychological flexibility inventory at baseline, week 8, and month 6 4. Self-efficacy is measured using the unidimensional self-efficacy scale at baseline, week 8, and month 6 | — |
Secondary
| Measure | Time frame |
|---|---|
| HCP phase: 1. Resilience is measured using the Connor-Davidson Resilience Scale at baseline, week 8, and month 6 2. Psychological flexibility is measured using the Multi-dimensional psychological flexibility inventory at baseline, week 8, and month 6 3. System useability is measured using the system useability scale at week 8 and month 6 4. ACT-based competencies are measured using the ACT knowledge questionnaire at week 8 PwMS phase: 1. Overall health is measured using a general health visual analogue scale at baseline, week 8, and month 6 2. Mood (anxiety, depression) is measured using the Hospital anxiety and depression scale at baseline, week 8, and month 6 3. Impact of MS is measured using the Multiple Sclerosis Impact scale at baseline, week 8, and month 6 4. System useability is measured using the system useability scale at week 8 and month 6 | — |
Countries
England, United Kingdom, Wales
Contacts
Public ContactCharli Wicks
Outcome results
None listed